Annual report pursuant to Section 13 and 15(d)

Statement of Stockholders' Deficit

v3.19.1
Statement of Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Dec. 31, 2016   $ 46,703 $ 15,060,616 $ (18,226,179) $ (3,118,860)
Balance at beginning (in shares) at Dec. 31, 2016   46,702,836      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of convertible note payable and accrued interest into common stock   $ 1,705 115,770   117,475
Conversion of convertible note payable and accrued interest into common stock (In shares)   1,704,968      
Conversion of related party accrued Interest into common stock   $ 21 2,116   2,137
Conversion of related party accrued Interest into common stock (in shares)   21,370      
Conversion of accrued Interest into common stock   $ 1,508 77,661   79,169
Conversion of accrued Interest into common stock (in shares)   1,507,989      
Conversion of related party convertible note and accrued interest into common stock   $ 14,000 686,000   700,000
Conversion of related party convertible note and accrued interest into common stock (In shares)   14,000,000      
Issuance of Series A Preferred Stock for cash $ 55   549,945   550,000
Issuance of Series A Preferred Stock for cash (In shares) 55,000        
Loss on extinguishment upon conversion of convertible note payable, related party     (170,813)   (170,813)
Issuance of common stock in exchange for consulting services   $ 500 26,900   27,400
Issuance of common stock in exchange for consulting services (in shares)   500,000      
Issuance of warrant to purchase common stock in exchange for consulting services     12,495   12,495
Stock based compensation     49,756   49,756
Reclassification of derivative liability     (547,466)   (547,466)
Net loss       (1,584,873) (1,584,873)
Balance at ending at Dec. 31, 2017 $ 55 $ 64,437 15,862,980 (19,811,052) (3,883,580)
Balance at ending (in shares) at Dec. 31, 2017 55,000 64,437,163      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of convertible note payable and accrued interest into common stock   $ 17,027 1,260,039   1,277,066
Conversion of convertible note payable and accrued interest into common stock (In shares)   17,027,544      
Issuance of Series A Preferred Stock for cash $ 28   274,972   275,000
Issuance of Series A Preferred Stock for cash (In shares) 27,500        
Loss on extinguishment upon conversion of convertible note payable, related party        
Issuance of common stock in exchange for consulting services   $ 3,667 326,333   330,000
Issuance of common stock in exchange for consulting services (in shares)   3,666,666      
Stock based compensation     175,076   175,076
Issuance of common stock in acquisition of CureDM Group Holdings LLC   $ 25,000 1,225,000   1,250,000
Issuance of common stock in acquisition of CureDM Group Holdings LLC (in shares)   25,000,000      
Issuance of warrants to purchase capital stock in exchange for extension of note payable     21,121   21,121
Reclassification of derivative liability     10,617   10,617
Net loss       (3,601,217) (3,601,217)
Balance at ending at Dec. 31, 2018 $ 83 $ 110,131 $ 19,156,138 $ (23,412,269) $ (4,145,917)
Balance at ending (in shares) at Dec. 31, 2018 82,500 110,131,373